Type 2 Cytokines Weaken Mesenchymal Stem Cell Immunosuppression Through STAT6 Signalling
Researchers found that interleukin-4 and interleukin-13 impair the immunosuppressive activity of mesenchymal stem cells via STAT6 pathway activation.
Researchers found that interleukin-4 and interleukin-13 impair the immunosuppressive activity of mesenchymal stem cells via STAT6 pathway activation.
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.